Émilie Lanoy - Concepedia

Author

Émilie Lanoy

Also Known As

C Piketty, E LANOY, E Lanoy, E. Lanoy, EMILIE LANOY, Emilie LANOY, Emilie Lanoy, Emillie Lanoy, Lanoy, E., Lanoy, Emilie

162

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

Inserm Institut Gustave Roussy Sorbonne Université Assistance Publique – Hôpitaux de Paris Université Paris-Saclay

ÉL

About

Émilie Lanoy is an author at Inserm specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	2.4K
2	Public Health	4	4	341
3	Engineering	2	2	31
4	Management	1	1	89
5	Biostatistics	1	1	89

Émilie Lanoy

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab Nathalie Chaput, Patricia Lepage, Clélia Coutzac, Annals of Oncology InflammationDysbiosisMucosal ImmunologyBaseline Gut MicrobiotaGut Microbiology	2017	1.2K
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab Camille Hua, Lise Boussemart, Christine Mateus, JAMA Dermatology	2015	638
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease Lysiane Marthey, Christine Mateus, Charlotte Mussini, Journal of Crohn s and Colitis	2016	335
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival Julie Delyon, Céu Mateus, D. Lefeuvre, Annals of Oncology Improved SurvivalMedicineMelanomaImmunologyMetastatic Melanoma	2013	306
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease François‐Xavier Danlos, Anne-Laure Voisin, Valérie Dyevre, European Journal of Cancer Anti-programmed Death 1Inflammatory DiseaseAutoimmune DiseaseMedicinePre-existing Autoimmune	2018	304
When to Start Treatment? A Systematic Approach to the Comparison of Dynamic Regimes Using Observational Data Lauren E. Cain, James M. Robins, Émilie Lanoy, The International Journal of Biostatistics	2010	222
Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies S. Antoun, Émilie Lanoy, Roberto Iacovelli, Cancer	2013	216
Long-Term Survival in Patients Responding to Anti–PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation Marie-Léa Gauci, Émilie Lanoy, Stéphane Champiat, Clinical Cancer Research	2018	140
Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer S. Antoun, Isabelle Borget, Émilie Lanoy Current Opinion in Supportive and Palliative Care	2013	139
Frequency, determinants and consequences of delayed access to care for HIV infection in France Émilie Lanoy, Murielle Mary‐Krause, Pierre Tattevin, Antiviral Therapy	2007	132

Page 1